Pharma Journalist - Page 48 of 946 -

Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs

Alfasigma to Acquire Nordic Pharma in Global Expansion

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

Harbour BioMed, Bristol Myers Squibb Partner on Multi-Specific Antibodies

FDA Approves GSK’s Twice-Yearly Biologic for Severe Eosinophilic Asthma

Alnylam Expands Massachusetts Facility to Advance RNAi Manufacturing

Phase 3 Trial Shows Survival Gains in Muscle-Invasive Bladder Cancer

Takeda Reports Strong Phase 3 Results for Oral Psoriasis Therapy

FDA Approves First Subcutaneous Therapy for EGFR-Mutated Lung Cancer

FDA Grants Breakthrough Designation to Adrabetadex for Infantile NPC

Telix and Varian Partner to Advance Theranostic-Driven Cancer Care

Zealand Pharma and OTR Therapeutics Launch Collaboration on Metabolic Drugs

Formation Bio Acquires Global Rights to Next-Gen TYK2 Inhibitor